Phase Forward and SGS Life Science Services Sign Multi-Year, Multi-Million Dollar Agreement
WALTHAM, Mass.–(BUSINESS WIRE)–Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced a multi-year, multi-million dollar extension of its existing partnership with leading CRO SGS. The agreement reinforces the companies’ close working relationship and offers SGS’s customers the benefits of Phase Forward’s InForm™ Global Trial Management (GTM), Clarix™ Interactive Response Technology (IRT) and Maaguzi Web-based electronic patient reported outcomes (ePRO) and late phase solutions. A Phase Forward customer since 2002, SGS is one of the largest EU data management CROs, managing nearly 100 clinical trials and processing over one million case report form (CRF) pages each year.
“Our customers are looking for an integrated eClinical solution comprising multiple systems,” said Luc Braeken, global director, Biometrics Services, SGS. “The agreement announced today will allow us to respond to customer demand for this integrated solution with innovative product sets from a market leader. This solution is designed to meet the needs of even the most demanding clinical development professional, offering more effective ways to manage clinical operations, help ensure product safety and reduce time-to-market.”
“SGS has established a reputation as a leading provider of integrated solutions from preclinical activities, to phase one through four trials,” said Mike Davies, vice president, global CRO partnerships, Phase Forward. “We look forward to building on the success of our collaboration to date with the solutions that our acquisitions of Clarix and Maaguzi add to the equation.”
About SGS Life Science Services
SGS Life Science Services, a Business unit of the SGS Group, has 30 years of experience as a global contract service organization providing integrated solutions from preclinical activities to Phase I through IV trials, bio-analytical and QC testing. With more than 1,300 employees and 2,000 clinical trials performed, SGS Life Science Services serves the pharmaceutical, biotechnology and medical device industries. SGS Life Science Services Biometrics group offers comprehensive Data Management, Statistics, PK and medical writing services. Its expertise includes in-depth experience in EDC, CDISC and extensive high throughput capabilities to deliver on time.
The SGS Group is the global leader and innovator in inspection, verification, testing and certification services. Founded in 1878, SGS is recognized as the global benchmark in quality and integrity. With more than 56,000 employees, SGS operates a network of more than 1,000 offices and laboratories around the world. Additional information about SGS is available at www.sgs.com/CRO.
About Phase Forward
Phase Forward is a leading provider of integrated data management solutions for clinical trials and drug safety. Phase Forward’s products and services have been utilized in over 10,000 clinical trials involving more than 1,000,000 clinical trial study participants at over 290 organizations and regulatory agencies worldwide including: AstraZeneca, Boston Scientific, Dana-Farber Cancer Institute, Eli Lilly, the U.S. Food and Drug Administration, GlaxoSmithKline, Harvard Clinical Research Institute, Merck Serono, Novartis, Novo Nordisk, PAREXEL International, Procter & Gamble, Quintiles, sanofi-aventis, Schering-Plough Research Institute, Servier, SGS, Tibotec and the U.K. Medicines and Healthcare Products Regulatory Agency. Additional information about Phase Forward is available at www.phaseforward.com.
